Clinical Trials Logo

Stress Disorders, Post-Traumatic clinical trials

View clinical trials related to Stress Disorders, Post-Traumatic.

Filter by:

NCT ID: NCT03400813 Completed - Clinical trials for Post-Traumatic Stress Disorder

Eye-Movement Desensitization and Post-Traumatic Syndroms

SOFTER3
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

Millions people, all over the world, are admitted in the Emergency Department after a trauma or simply to receive medical cares. In France, it represents 10 million patients. Probably because of stress associated with the event, 20% will suffer a combination of non-specifics symptoms which persist for many months and with daily life quality impairment. The investigators hypothesize that an early intervention, such as Eye-Movement, Desensitization and Reprocessing (EMDR) could be performed in the ED and could prevent the occurrence of these symptoms.

NCT ID: NCT03391297 Recruiting - Clinical trials for Posttraumatic Stress Disorder

Shortened Prolonged Exposure Therapy for Chronic PTSD in Taiwanese Adults

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

The present study aimed to investigate the efficacy of 60-minute sessions of prolonged exposure (PE) for patients with posttraumatic stress disorder (PTSD) in Taiwan. A systematic case study will be employed to compare the efficacy of 60-minute PE session versus standard 90-minute session with eight Taiwanese PTSD patients. Participants will include the individuals aged 18 or older who meet a diagnosis of DSM-5 PTSD and to experience moderate to severe symptoms for at least 3 months. Those who have current substance dependence, psychosis, and acute suicidality (i.e., recent suicidal ideation with intent and plan) will be excluded. Participants will receive 10-15 weekly session of PE treatment with 60- or 90-minute sessions. The investigators hypothesized that: (a) 60-minute PE is as effective as 90-minute PE in reducing PTSD and depressive symptoms as well as in promoting posttraumatic growth (PTG); and (b) the treatment gains will be maintained at 3-month follow-up.

NCT ID: NCT03384706 Completed - Clinical trials for Posttraumatic Stress Disorder

A Comparison of CPT Versus ART Versus WL

Start date: September 6, 2017
Phase: N/A
Study type: Interventional

The purpose of this research study is to compare the effectiveness of two treatments for the symptoms of Posttraumatic Stress Disorder (PTSD) with a no therapy, wait-list control condition. The two treatments are Cognitive Processing Therapy (CPT) as compared to Accelerated Resolution Therapy (ART). Both have been found to be effective with veterans and civilians in prior studies but they have never been compared to one another. Participants will be 280 males and females ages 18 and older who meet criteria for PTSD (or subthreshold PTSD). PTSD is a condition that can occur after a trauma experience such as combat, sexual abuse, physical abuse, or natural disasters.

NCT ID: NCT03383536 Recruiting - Clinical trials for Posttraumatic Stress Disorder

Neuroeconomics of Social Behavior Following Trauma Exposure

Start date: November 14, 2017
Phase:
Study type: Observational

This study will use a neuroeconomic paradigm with state-of-the-art imaging protocols to probe abnormal social reward processing underlying social withdrawal in symptomatic trauma-exposed women. By also gathering self-report measures of social anhedonia, performance on non-social and social reward valuation tasks, and measures of real-world social functioning including social network size, we aim to specify how alterations in social reward processing result in social withdrawal and functional impairment.

NCT ID: NCT03376633 Completed - Depression Clinical Trials

The Impact of a School-Based, Trauma-Informed CBT Intervention for Young Women

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is: 1. To conduct a randomized controlled trial to evaluate the impact of Working on Womanhood (WOW), a school-based, trauma-informed counseling and clinical mentoring program for young women in Chicago, on PTSD, anxiety, depression. In addition, this study will examine the effect of WOW on other, secondary outcomes such as school discipline, GPA, high school graduation, and criminal justice involvement, risky behaviors, and other social-emotional learning outcomes. 2. To evaluate the cost-effectiveness of the WOW program.

NCT ID: NCT03376139 Withdrawn - Clinical trials for Alcohol Use Disorder

Zonisamide Outpatient Study

Start date: March 1, 2019
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine if, compared to placebo, zonisamide (400mg/day) is a safe and efficacious treatment for post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) in Veterans with PTSD and co-occurring AUD.

NCT ID: NCT03375294 Completed - Clinical trials for Post Traumatic Stress Disorder

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

tN2O
Start date: April 1, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)

NCT ID: NCT03372460 Completed - Clinical trials for Post-Traumatic Stress Disorder

tDCS Plus Virtual Reality for PTSD

TAVRE
Start date: April 2, 2018
Phase: N/A
Study type: Interventional

This study will test the effectiveness of combining non-invasive brain stimulation, called transcranial direct current stimulation (tDCS), with virtual reality exposure as a treatment for Veterans with chronic posttraumatic stress disorder (PTSD). Investigators will test whether this intervention improves PTSD symptoms and improves quality of life. Results from this study may be used to develop a new non-medication approach to treating chronic PTSD.

NCT ID: NCT03371654 Recruiting - Healthy Clinical Trials

Estrogen and Fear (PTSD)

Start date: June 24, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to determine if taking a pill of estradiol (E2) together with prolonged exposure (PE) therapy can improve this treatment outcome in women diagnosed with Post-Traumatic Stress Disorder (PTSD). 80 subjects will take part in this research study across NYU Langone Health and UPenn (40 subjects at each site). Participants will be randomized into one of two groups, PE + E2 or PE + placebo. The study will include preliminary screening and baseline visits, experimental visits, and therapy visits over the course of six weeks. Several follow-up visits will take place.

NCT ID: NCT03367533 Completed - Bipolar Disorder Clinical Trials

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Start date: November 29, 2018
Phase: Phase 1
Study type: Interventional

The proposed study will assess the combined effect of perampanel and ketamine on the anti-depressant response in individuals with treatment resistant depression. The purpose of this study is to test the hypothesis that stimulation of Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid receptors (AMPAR) is critical to the anti-depressant response of ketamine.